Transparency Market Research Report Added "Biotech API Manufacturing Services Market" to its database.

Albany, NY -- (SBWire) -- 11/22/2016 --A new market research report published by Transparency Market Research, titled "Biotech API Manufacturing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019Top of FormBottom of Form," studies the market from different angles to present a comprehensive picture. It presents the current competitive landscape and growth opportunities using data procured from various sources and insightful inputs from industry experts.

The report uses SWOT analysis, which studies strengths, weaknesses, opportunities, and threats of key players to uncover the potential of the market. Market vendors can derive insights from it to strategize sensibly. Further, the report leverages distinctive graphics to package key market figures in a much more meaningful manner.

The market for biotech API manufacturing services involves contract services for the production of biotechnology-related active pharmaceutical ingredients (API). Biotech APIs entail the manufacturing of active ingredients from human, animal, microbial, or genetically engineered origin using biological processes. Compared to the well-entrenched market for chemically synthesized API manufacturing services, the market for biotech API manufacturing services is still in a nascent form. The current macro and micro environment are highly conducive for the growth of the biotech API manufacturing services market, finds a TMR analyst.

The report states that the market would register robust growth in the coming years on the heels of the soaring popularity of biotechnology products. Tailwind to the market will also be supplied by relatively small-sized biotech companies holding intellectual property rights for novel biologics. One big advantage of contract manufacturing services, the report points out, is better quality products at competitive prices. Companies, to whom manufacturing services have been outsourced, have expertise and economies of scale in these operations. This enables them to supply superior products at reasonable rates to bigger biotech companies, who focus primarily on developing new biologics after extensive research.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2336

The global market for biotech API manufacturing can be divided into the following: recombinant proteins production, monoclonal antibody manufacturing, insulin analogues manufacturing, mammalian cell culture manufacturing, interferon manufacturing, growth hormone API manufacturing, and vaccine manufacturing. Among them, the mammalian cell culture manufacturing services segment has been the highest grosser in the global biotech API manufacturing services market.

Geography-wise, the global market for biotech API manufacturing services can be divided into Europe, Asia Pacific, North America, and the Rest of the World. The market in the emerging economies in Asia Pacific has registered steady growth on a par with advanced economies because of low operating costs. India and China markets are expected to expand three times faster than the Western Europe market. Further, improved trade ties between Taiwan and China is driving the market in the region.

Some of the top companies in the market listed in the report are: Biogen Idec International GmbH, Boehringer Ingelheim BioXcellence (part of Boehringer Ingelheim Pharma GmbH & Co KG), GSK Biopharmaceuticals, Biocon Ltd., and Novo Nordisk.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/